Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
ACS Chem Biol ; 10(9): 2158-65, 2015 Sep 18.
Article in English | MEDLINE | ID: mdl-26131766

ABSTRACT

Over the past decade, DNA and RNA aptamers have attracted keen research interest due to their ability to specifically bind targets of therapeutic relevance. However, their application is often hampered by a short serum half-life and missing effector functions. Conjugation of aptamers to antibody Fc fragments could improve pharmacokinetics, enable immune effector mechanisms, and provide an option for the introduction of desired payloads (e.g., toxins or fluorescent dyes). We developed a modular scaffold-supported system based on human IgG1 Fc fragments, which allows for its dual functionalization with moieties of interest. In our approach, two bioorthogonal, enzyme-mediated reactions were used in combination with oxime ligation and self-assembly based on PNA-DNA base pairing. Thus, an engineered synthetic peptide nucleic acid (PNA) oligomer was coupled to the C-termini of the Fc dimer upon sequence-specific sortase A-mediated transpeptidation. Hybridization of the resulting Fc-PNA conjugate with a tailored DNA aptamer that binds cancer-related hepatocyte growth factor receptor (c-MET) led to a hybrid construct which showed strong and specific binding to c-MET and was readily internalized by c-MET-overexpressing cells. To install an additional orthogonally addressable site, aldehyde tag technology was applied followed by oxime ligation with an aminooxy-bearing fluorescent dye as model cargo. Delivery of fluorescent probe specifically to c-MET-overexpressing cells was confirmed by flow cytometry. Our approach can provide access to engineered aptamer-Fc conjugates with desired target specificity and cytotoxic payloads.


Subject(s)
Aptamers, Nucleotide/metabolism , Drug Delivery Systems , Immunoconjugates/chemistry , Immunoglobulin Fc Fragments/chemistry , Peptide Nucleic Acids/chemistry , Proto-Oncogene Proteins c-met/metabolism , Amino Acid Sequence , Aptamers, Nucleotide/chemistry , Cell Line, Tumor , Fluorescent Dyes/administration & dosage , HEK293 Cells , Humans , Neoplasms/drug therapy , Neoplasms/metabolism
2.
MAbs ; 7(1): 138-51, 2015.
Article in English | MEDLINE | ID: mdl-25523975

ABSTRACT

There is growing interest in the fast and robust engineering of protein pH-sensitivity that aims to reduce binding at acidic pH, compared to neutral pH. Here, we describe a novel strategy for the incorporation of pH-sensitive antigen binding functions into antibody variable domains using combinatorial histidine scanning libraries and yeast surface display. The strategy allows simultaneous screening for both, high affinity binding at pH 7.4 and pH-sensitivity, and excludes conventional negative selection steps. As proof of concept, we applied this strategy to incorporate pH-dependent antigen binding into the complementary-determining regions of adalimumab. After 3 consecutive rounds of separate heavy and light chain library screening, pH-sensitive variants could be isolated. Heavy and light chain mutations were combined, resulting in 3 full-length antibody variants that revealed sharp, reversible pH-dependent binding profiles. Dissociation rate constants at pH 6.0 increased 230- to 780-fold, while high affinity binding at pH 7.4 in the sub-nanomolar range was retained. Furthermore, binding to huFcRn and thermal stability were not affected by histidine substitutions. Overall, this study emphasizes a generalizable strategy for engineering pH-switch functions potentially applicable to a variety of antibodies and further proteins-based therapeutics.


Subject(s)
Amino Acid Substitution , Antibodies, Monoclonal, Humanized , Immunoglobulin Heavy Chains , Immunoglobulin Light Chains , Adalimumab , Antibodies, Monoclonal, Humanized/chemistry , Antibodies, Monoclonal, Humanized/genetics , Gene Library , Histidine , Humans , Hydrogen-Ion Concentration , Immunoglobulin Heavy Chains/chemistry , Immunoglobulin Heavy Chains/genetics , Immunoglobulin Light Chains/chemistry , Immunoglobulin Light Chains/genetics , Protein Structure, Tertiary , Saccharomyces cerevisiae
3.
Angew Chem Int Ed Engl ; 53(47): 12941-5, 2014 Nov 17.
Article in English | MEDLINE | ID: mdl-25296746

ABSTRACT

A series of novel bioactive derivatives of the sunflower trypsin inhibitor-1 (SFTI-1) suitable for hyperpolarization by parahydrogen-induced polarization (PHIP) was developed. The PHIP activity was achieved by labeling with L-propargylglycine, O-propargyl-L-tyrosine, or 4-pentynoic acid. (1) H NMR signal enhancements (SE) of up to a factor of 70 were achieved in aqueous solution. We found that an isolated spatial location of the triple bond within the respective label and its accessibility for the hydrogenation catalyst are essential factors for the degree of signal enhancement.


Subject(s)
Alkynes/chemistry , Fatty Acids, Unsaturated/chemistry , Glycine/analogs & derivatives , Magnetic Resonance Spectroscopy/methods , Peptides, Cyclic/chemistry , Tyrosine/analogs & derivatives , Catalysis , Glycine/chemistry , Hydrogenation , Models, Molecular , Molecular Structure , Protons , Tyrosine/chemistry
4.
Chem Commun (Camb) ; 49(71): 7839-41, 2013 Sep 14.
Article in English | MEDLINE | ID: mdl-23887355

ABSTRACT

The unsaturated side chain of l-propargylglycine (Pra) was used to study parahydrogen-induced polarization (PHIP) in synthetic oligopeptides. For the first time PHIP-induced NMR signal enhancement was demonstrated using model peptides bearing various functional side chains.


Subject(s)
Alkynes/chemistry , Glycine/analogs & derivatives , Oligopeptides/chemical synthesis , Amino Acid Sequence , Catalysis , Glycine/chemistry , Hydrogen/chemistry , Hydrogenation , Magnetic Resonance Spectroscopy , Oligopeptides/chemistry , Sulfhydryl Compounds/chemistry
5.
Molecules ; 17(11): 12533-52, 2012 Oct 24.
Article in English | MEDLINE | ID: mdl-23095896

ABSTRACT

Cystine-knot peptides display exceptional structural, thermal, and biological stability. Their eponymous motif consists of six cysteine residues that form three disulfide bonds, resulting in a notably rigid structural core. Since they highly tolerate either rational or combinatorial changes in their primary structure, cystine knots are considered to be promising frameworks for the development of peptide-based pharmaceuticals. Despite their relatively small size (two to three dozens amino acid residues), the chemical synthesis route is challenging since it involves critical steps such as head-to-tail cyclization and oxidative folding towards the respective bioactive isomer. Herein we describe the topology of cystine-knot peptides, their synthetic availability and briefly discuss potential applications of engineered variants in diagnostics and therapy.


Subject(s)
Cystine-Knot Miniproteins/chemical synthesis , Amino Acid Sequence , Cyclization , Cystine Knot Motifs , Cystine-Knot Miniproteins/chemistry , Drug Design , Humans , Models, Molecular , Molecular Sequence Data , Oxidation-Reduction , Protein Folding , Protein Stability
SELECTION OF CITATIONS
SEARCH DETAIL
...